{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:38:34Z","timestamp":1785368314597,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["id 2021-10840-F1"],"award-info":[{"award-number":["id 2021-10840-F1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09618-2","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:44:19Z","timestamp":1772847859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prophylactic para-aortic irradiation vs pelvic radiotherapy in pelvic node-positive carcinoma cervix in the setting of concurrent chemoradiation: a phase II open-label multi centric randomized controlled trial (PRO-PARA)"],"prefix":"10.1186","volume":"27","author":[{"name":"PROPARA Trialist Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3714-1195","authenticated-orcid":false,"given":"Tapesh","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santam","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"GY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Lewis Christabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritanjali","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurupa","family":"Mahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekripa","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oindrila","family":"Roychowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sougata","family":"Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"15","key":"9618_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"HM Keys","year":"1999","unstructured":"Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154\u201361. https:\/\/doi.org\/10.1056\/NEJM199904153401503.","journal-title":"N Engl J Med"},{"issue":"8","key":"9618_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"WA Peters 3rd","year":"2000","unstructured":"Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606\u201313. https:\/\/doi.org\/10.1200\/JCO.2000.18.8.1606.","journal-title":"J Clin Oncol"},{"issue":"15","key":"9618_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144\u201353. https:\/\/doi.org\/10.1056\/NEJM199904153401502.","journal-title":"N Engl J Med"},{"key":"9618_CR4","doi-asserted-by":"crossref","unstructured":"Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17(5):1339\u20131339. Available from: http:\/\/incan-mexico.org\/wp_ginecologia\/wp-content\/uploads\/GOG-085.pdf.","DOI":"10.1200\/JCO.1999.17.5.1339"},{"issue":"2","key":"9618_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002225.pub2","volume":"2015","author":"J Green","year":"2005","unstructured":"Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005;(2):002225. https:\/\/doi.org\/10.1002\/14651858.CD002225.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"9618_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","volume":"4","author":"S Shrivastava","year":"2018","unstructured":"Shrivastava S, Mahantshetty U, Engineer R, Chopra S, Hawaldar R, Hande V, et al. Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial. JAMA Oncol. 2018;4(4):506\u201313. https:\/\/doi.org\/10.1001\/jamaoncol.2017.5179.","journal-title":"JAMA Oncol"},{"issue":"3","key":"9618_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.radonc.2016.03.020","volume":"120","author":"L Fokdal","year":"2016","unstructured":"Fokdal L, Sturdza A, Mazeron R, Haie-Meder C, Tan LT, Gillham C, et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study. Radiother Oncol. 2016;120(3):434\u201340. https:\/\/doi.org\/10.1016\/j.radonc.2016.03.020.","journal-title":"Radiother Oncol"},{"issue":"4","key":"9618_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","volume":"22","author":"R P\u00f6tter","year":"2021","unstructured":"P\u00f6tter R, Tanderup K, Schmid MP, J\u00fcrgenliemk-Schulz I, Haie-Meder C, Fokdal LU, et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021;22(4):538\u201347. https:\/\/doi.org\/10.1016\/S1470-2045(20)30753-1.","journal-title":"Lancet Oncol"},{"issue":"3","key":"9618_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0360-3016(90)90475-y","volume":"19","author":"M Rotman","year":"1990","unstructured":"Rotman M, Choi K, Guse C, Marcial V, Hornback N, John M. Prophylactic irradiation of the para-aortic lymph node chain in stage IIB and bulky stage IB carcinoma of the cervix, initial treatment results of RTOG 7920. Int J Radiat Oncol Biol Phys. 1990;19(3):513\u201321. https:\/\/doi.org\/10.1016\/0360-3016(90)90475-y.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9618_CR10","doi-asserted-by":"crossref","unstructured":"Rotman M, Pajak TF, Choi K, Clery M, Marcial V, Grigsby PW, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79\u201320. JAMA. 1995;274(5):387\u201393. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7616634.","DOI":"10.1001\/jama.1995.03530050035029"},{"key":"9618_CR11","doi-asserted-by":"crossref","unstructured":"Haie C, Pejovic MH, Gerbaulet A, Horiot JC, Pourquier H, Delouche J, et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol. 1988;11(2):101\u201312. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3281186.","DOI":"10.1016\/0167-8140(88)90245-9"},{"key":"9618_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.radonc.2021.08.020","volume":"163","author":"M Peters","year":"2021","unstructured":"Peters M, de Leeuw AAC, Nomden CN, Tanderup K, Kirchheiner K, Lindegaard JC, et al. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: an EMBRACE analysis. Radiother Oncol. 2021;163:150\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2021.08.020.","journal-title":"Radiother Oncol"},{"key":"9618_CR13","unstructured":"Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. Int J Radiat Oncol Biol Phys. 2013;87(3):542\u20138. Available from: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-84884889919&doi=10.1016%2fj.ijrobp.2013.06.2059&partnerID=40&md5=e9e1cbffc125015d96dca2afd50ab362."},{"key":"9618_CR14","doi-asserted-by":"crossref","unstructured":"Chopra S, Gupta S, Kannan S, Dora T, Engineer R, Mangaj A, et al. Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial. J Clin Oncol Official J Am Soc Clin Oncol. 2021;39(33):3682\u201392. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34506246\/.","DOI":"10.1200\/JCO.20.02530"},{"key":"9618_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.579410","volume":"10","author":"W Wang","year":"2020","unstructured":"Wang W, Zhou Y, Wang D, Hu K, Zhang F. Prophylactic extended-field irradiation in patients with cervical cancer: a literature review. Front Oncol. 2020;10:579410. https:\/\/doi.org\/10.3389\/fonc.2020.579410.","journal-title":"Front Oncol"},{"key":"9618_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.radonc.2019.02.007","volume":"134","author":"CN Nomden","year":"2019","unstructured":"Nomden CN, P\u00f6tter R, de Leeuw AAC, Tanderup K, Lindegaard JC, Schmid MP, et al. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: patterns of failure in the EMBRACE study cohort. Radiother Oncol. 2019;134:185\u201390. https:\/\/doi.org\/10.1016\/j.radonc.2019.02.007.","journal-title":"Radiother Oncol"},{"issue":"3","key":"9618_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s10278-021-00576-6","volume":"35","author":"S Kundu","year":"2022","unstructured":"Kundu S, Chakraborty S, Mukhopadhyay J, Das S, Chatterjee S, Achari RB, et al. Design and development of a medical image databank for assisting studies in radiomics. J Digit Imaging. 2022;35(3):408\u201323. https:\/\/doi.org\/10.1007\/s10278-021-00576-6.","journal-title":"J Digit Imaging"},{"key":"9618_CR18","doi-asserted-by":"crossref","unstructured":"Mc Cormack M, Rincon DG, Eminowicz G, Diez P, Farrelly L, Kent C, et al. 154 A randomized phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer. The GCIG INTERLACE trial. Int J Gynecol Cancer. 2024;34(Suppl 1). Available from: https:\/\/ijgc.bmj.com\/content\/34\/Suppl_1\/A1.2.abstract. Cited 2024 Sep 4.","DOI":"10.1136\/ijgc-2024-ESGO.2"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09618-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09618-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09618-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:58:15Z","timestamp":1772999895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09618-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9618"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09618-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Institutional Review Board of Tata Medical Center vide approval letter number 2021\/TMC\/240\/IRB52 dated 10th October 2022. Additionally, IRB approval has been obtained from Post Graduate Institute of Medical Education and Research vide approval letter number PGI\/IEC\/2023\/000037 dated 04\/02\/2023. All patients are provided with a patient information sheet translated into the vernacular language, and written informed consent is obtained before accrual. IRB approval from KMC Manipal and AIIMS Patna are awaited.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Model consent form and participant information sheet are available as Appendix 1.\nNo identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"195"}}